Three years after the Dobbs decision, the legal challenges continue for activists on both sides of the abortion debate.

Speaking at BIO2025, rare disease leaders from Ultragenyx, Amylyx and Yale questioned the need for the new regulatory pathway ...

The Food and Drug Administration (FDA) announced a new crackdown Wednesday on the flow of American DNA to labs in ...

Although the company withheld detailed findings from the study of treatment-resistant depression, analysts at Stifel called ...

In the wake of Marks' exit, FDA commissioner Marty Makary, M.D., named Vinay Prasad, M.D., to head up CBER. In addition to that title, Prasad recently added the title of "chief medical and science ...

Curay, the FDA’s acting top drug regulator, is stepping down from her post after serving at the agency for more than eight ...

The U.S. Food and Drug Administration (FDA) has initiated an immediate review of clinical trials involving the international ...

And more health news stories you need to start your week.

Novo Nordisk is halting its collaboration with Hims & Hers Health over the sale of weight loss drugs, STAT says. The ...

The number of abortions in the U.S. accessed through telemedicine is growing. So are the challenges to this mechanism that ...